H.C. Wainwright has recently initiated OptiNose Inc (OPTN) stock to Buy rating, as announced on March 11, 2024, according to Finviz. Earlier, on August 21, 2023, Lake Street had initiated the stock to Buy, setting a price target of $3. Jefferies also resumed Buy rating with a price target of $5. Additionally, RBC Capital Mkts resumed Outperform rating on April 7, 2021, with a target price of $17. Cowen analysts, in their report published on December 18, 2019, also initiated Outperform rating and set a price target of $25 for OptiNose Inc’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.
Sponsored
OptiNose Inc (OPTN) Stock Trading Recap
On Monday, OptiNose Inc (OPTN) stock saw a decline, ending the day at $0.89 which represents a decrease of $-0.01 or -1.11% from the prior close of $0.9. The stock opened at $0.94 and touched a low of $0.88 during the day, reaching a high of $0.95. The volume of shares traded was 0.50 million falling short of the average volume of 0.72 million.
OPTN Stock Performance and Moving Averages
In recent trading, OptiNose Inc (OPTN) stock price has shown some volatility, fluctuating -7.66% over the last five trades and -3.70% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by -52.87%, and it has plunged by -23.28% in the previous three months. Currently, OPTN is trading at -8.11%, -12.69%, and -27.07% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.
As of the latest trading close, OPTN, a Healthcare sector stock, is trading -57.80% below its 52-week high but remains 10.76% above its 52-week low. The Average True Range (ATR) (14 days) of 0.06 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.
OptiNose Inc’s Profitability and Valuation Ratios
OptiNose Inc’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of -25.09% and a profit margin of -54.50%, with a gross margin of -52.87%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.
In terms of valuation, OptiNose Inc’s market capitalization stands at $133.61 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. Additionally, the Price-to-Sales Ratio is 1.78, reflecting the market’s valuation of the company’s sales.
Understanding Insider Trading
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 21.03% of OptiNose Inc (OPTN)’s shares, while financial institutions hold 62.59%.
Notable insider trades include Mahmoud Ramy A, Chief Executive Officer at OptiNose Inc (OPTN), who sold 111426 shares on Jul 17 ’24, at $1.14 each, totaling $0.13 million.
